+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles



Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles



International Journal of Nanomedicine 6: 445-452



Polybutylcyanoacrylate (PBCA) nanoparticles coated with polysorbate-80 have been extensively proposed for delivering drugs into the animal brain and have shown great potential for therapeutic applications. In this study, we made an attempt to deliver the chemotherapeutic drug, temozolomide, into the brain by using PBCA nanoparticles. The physicochemical characteristics, in vitro release, and brain targeting ability of the drug-loaded nanoparticles were investigated. Our results show that a significantly higher concentration of temozolomide in the form of polysorbate-80-coated PBCA nanoparticles was observed in the brain (P < 0.05) in comparison with the free drug. This study indicates that polysorbate-80 coated PBCA nanoparticles could be a feasible carrier for temozolomide delivery to the brain. It is anticipated that the developed formulation may improve on targeted therapy for malignant brain tumors in the future.

(PDF emailed within 0-6 h: $19.90)

Accession: 052982505

Download citation: RISBibTeXText

PMID: 21445277

DOI: 10.2147/IJN.S16570


Related references

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharmaceutical Research 16(12): 1836-1842, 2000

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharmaceutical Research (New York) 16(12): 1836-1842, 1999

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharmaceutical Research (new York). 14(3): 325-328, 1997

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. Journal of Microencapsulation 15(1): 67-74, 1998

Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. International Journal of Pharmaceutics 310(1-2): 213-219, 2006

Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model. Brain Research 1261: 91-99, 2010

Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80. Bulletin of Experimental Biology and Medicine 145(2): 259-262, 2008

Polybutylcyanoacrylate nanoparticles covered with polysorbate-80 are responsible for the transport of tubocurarine sorbed on them to the brain perfused in situ. Eksperimental'naya i Klinicheskaya Farmakologiya 61(2): 23-26, March-April, 1998

Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells. European Journal of Neuroscience 12(6): 1931-1940, 2000

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharmaceutical Research (New York) 16(10): 1564-1569, 1999

Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 70(1): 75-84, 2008

Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomaterials 25(15): 3065-3071, 2004

A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration. Journal of Biomedical Nanotechnology 14(7): 1252-1262, 2018

Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats. Journal of Pharmacy and Pharmacology 67(12): 1650-1662, 2016

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Research 1200: 159-168, 2008